Log In
Print this Print this

Rifaximin soluble solid dispersion (SSD)

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionNext-generation rifaximin, a non-absorbed broad-spectrum antibiotic
Molecular Target Bacterial RNA polymerase (RNAP)
Mechanism of ActionRNA polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCirrhosis
Indication DetailsPrevent the complications of early decompensated liver cirrhosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today